Silver Sponsor - Exact Sciences

Exact Sciences

Exact Sciences is a leading provider of cancer screening and genomic-based diagnostic tests. From earlier detection to treatment guidance, they are helping people get the answers they need to make more informed decisions.

Through their pipeline efforts, they want to change the way cancer is diagnosed and treated by finding it earlier and providing better information to patients and clinicians at every step of the cancer journey.

Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease.

Their Oncotype DX Breast Recurrence Score® test is the only genomic test validated for its ability to predict the likelihood of chemotherapy benefit as well as the risk of recurrence in early-stage breast cancer.

The test is designed to facilitate personalised clinical decisions by providing information about the biology of an individual breast cancer, with the potential to deliver financial benefits for healthcare systems.

To date, the Oncotype DX® test, has been used in more than one million patients worldwide to guide their treatment decisions.

To find out more about Exact Sciences, please visit their website:

To find out more about the Oncotype DX® test, please visit their product website: